P1-146: Primary tracheal tumours  by Patané, Ana K. et al.
Copyright © 2007 by the International Association for the Study of Lung Cancer S609
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
were 198 thoracoscopic talc pleurodesis, 39 pleuroperitoneal shunts, 
37 pleurodesis via an intercostal drain, 28 pleural biopsies alone and 9 
long term drains. Referring physicians provided survival data. Factors 
signiﬁcance were examined with the log rank test (Kaplein-Meir), those 
signiﬁcant entered a Cox logistic multivariate regression analysis.
Results: Median follow up 1288 days (range 173-2329) 100% com-
plete. Median post-operative survival was 211 days (95%CI 169-253). 
Survival was not signiﬁcantly different by procedure performed or tu-
mour type. MPM had a median survival of 297 days (95%CI 236-358). 
Univarate analysis: Pre-operative leucocytosis, hypoxaemia, raised 
alanine transaminase, hypoalbuminaemia were associated with reduced 
post-operative survival. Multivarate analysis: leucocytosis (p<0.0001), 






WCC >12 53 68 36 - 100 <0.00001
 <12 254 259 207 - 311  
pO2 >9.5 98 317 220 - 414 0.0015
 <9.5 131 130 75 - 185  
Albumin >35 104 667 449 - 885 <0.000001
 <35 202 114 87 - 141
Conclusions: Surgical palliation can be individualised depending upon 
prognosis. Survival following palliation of MPM is the benchmark for 
the results of radical surgery.
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Background: Primitive tracheal tumors are extremely infrequent le-
sions which correspond to 2% of all upper airway neoplastic patholo-
gies and to 0.01% of all malignant lung diseases. The objective is to 
evaluate the survival of these patients according to their histological 
type, length of resection and characteristics of the tracheal margins.
Materials and Methods: retrospective study of a descriptive type 
analyzed over ten year-periods. An examination was conducted of all 
patients diagnosed and treated for a primitive tracheal tumor at “Maria 
Ferrer” Respiratory Rehabilitation Hospital from January 1971 to May 
2006. Out of 48 patients, ranging from 9 to 79 years of age, 29 were 
female and 19 were male.
Results: The most frequent tumor was adenocystic carcinoma, fol-
lowed in frequency by epidermoid carcinoma. The duration of symp-
toms until diagnosis was 10 months and 33% of these patients were 
wrongly treated for asthma. Deobstruction, through rigid bronchoscopy, 
was successful as a bridge towards surgery, and it was reserved for 
use as an exclusive treatment for benign tumors or with a palliative 
criterion in non-resectable tumors. The lowest one-third was the most 
affected tracheal segment.
Conclusions: The best results in this group of patients are related to 
resections which were less than 6 cm long and had negative margins.
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Background: To retrospectively evaluate the role of postoperative 
radiotherapy (RT) in the management of thymic tumors (TT). 
Methods: From 1995 to 2004, 10 pts (4 females, 6 males) with his-
tologically proven TT (4 tymoma, 6 tymic carcinoma) were treated at 
our department. The median age of the pts was 42 years (19-73 yrs). 
According to Masoaka staging system, there was 1 stage 1, 3 stage 
2, 4 stage 3, 1 stage 4-A, 1 stage 4-B pts. Eight pts were treated with 
total resection and postoperative RT with the median dose of 5940 cGy 
(5040-6000 cGy) in 28-30 fractions. One case who was treated with cu-
rative RT, only received 1620 cGy and 1 cycles of chemotherapy (CT) 
and died in three months. One case who had stage 4-B tymic carcinoma 
was treated with total exicion and metastasectomy and chemotherapy. 
One case who has stage 1 tymoma was treated with RT due to high 
mitoses (6/10) and high proliferative index (Ki-67: 104/1000). The 
histological subtype was in most of cases squamous cell carcinoma. 
Results: All cases were evaluated at January 2007. The median fol-
low-up time was 48 months (3-84 months). Five pts were living at 
the evaluating time. There were 6 complete surgical resections with 
postoperative RT (2 of these also were received CT-median 6 cycles), 
2 incomplete resections followed by chemoradiotherapy (paclitaxel 
60-70 mg/m2/weekly), 1 complete resection and metastasectomy with 
CT (This pt were administered second-line CT and RT), 1 with curative 
RT and CT as the initial treatment. Prior to surgery 1 pt had Myastenia 
Gravis. The median and 2-4 year overall survival rates were 48 months 
(3-84 months), %74, %47, respectively. The median overall survival 
was 34 months (28-49 months) and 48 months (3-84 months) for pts 
with tymoma and tymic carcinoma, respectively. Recurrences were 
seen at mediastinum, and pericardium at the median 47 months (12-54 
months) for 4 pts (4/8, 50%) (2 complete, and 2 incomplete resection, 
and 2 tymic carcinoma and 2 tymoma). Local control rate was 50% in 
the median follow-up time. After the recurrences, pts were treated with 
chemotherapy, surgery and reirradiation with 3960 cGy. The mean and 
2-4 year disease-free survival rates were 47 months (12-62 months), 
75%, 62,5% respectively excluding the pts who have metastatic or died 
at treatment.
Conclusion: The use of surgery and postoperative RT lead to good 
control of residual disease and high overall survival rates. 
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Background: Primary malignant tumors of the trachea are very rare. 
Of these, 50% were squamous cell carcinomas (SCC) and 20% to 35% 
were adenoid cystic carcinomas (ACC). The most frequent site of 
tumour is the lower third of the trachea. Symptoms often mimic astma 
